116 related articles for article (PubMed ID: 3609184)
1. Enrichment of progenitor cells from human marrow.
Baines P; Masters G; Booth M; Jacobs A
Exp Hematol; 1987 Aug; 15(7):809-13. PubMed ID: 3609184
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against human hemopoietic cells and the separation of progenitor cells from bone marrow.
Mouchiroud G; Berthier R; Newton IA; Chapel A; Hollard D
Exp Hematol; 1985 Jul; 13(6):566-73. PubMed ID: 3996493
[TBL] [Abstract][Full Text] [Related]
3. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
5. Myeloid and erythroid hemopoiesis supported by human bone marrow fibroblasts in vitro.
Cao WH; Wang QR; Xu YH
Chin Med J (Engl); 1992 Jul; 105(7):544-8. PubMed ID: 1451558
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
8. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
[TBL] [Abstract][Full Text] [Related]
9. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
[TBL] [Abstract][Full Text] [Related]
10. Purification of peripheral blood hematopoietic cells using Campath-1M monoclonal antibody.
Law P; Chau WK; Dooley DC
Exp Hematol; 1990 May; 18(4):289-93. PubMed ID: 2323363
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
Gallicchio VS; Casale GP; Watts T
Exp Hematol; 1987 Dec; 15(11):1099-102. PubMed ID: 3678410
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
14. Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages.
Kobayashi M; Imamura M; Uede T; Sakurada K; Maeda S; Iwasaki H; Tsuda Y; Musashi M; Miyazaki T
Stem Cells; 1994 May; 12(3):316-21. PubMed ID: 7521241
[TBL] [Abstract][Full Text] [Related]
15. A fractionation procedure of mouse bone marrow cells yielding exclusively pluripotent stem cells and committed progenitors.
Bauman JG; Wagemaker G; Visser JW
J Cell Physiol; 1986 Jul; 128(1):133-42. PubMed ID: 2424920
[TBL] [Abstract][Full Text] [Related]
16. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
17. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of mixed colony-forming cells in normal human bone marrow and blood.
Dresch C; Barreau P
Exp Hematol; 1985 Dec; 13(11):1143-51. PubMed ID: 4065263
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of interferon-gamma to high affinity receptors on human erythroid colony-forming cells.
Taniguchi S; Dai CH; Krantz SB
Exp Hematol; 1997 Mar; 25(3):193-8. PubMed ID: 9091293
[TBL] [Abstract][Full Text] [Related]
20. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
